loading page

G6PD deficiency in Hansen’s disease: A preventable peril!
  • Arnab Ghorui,
  • Pratap Patra
Arnab Ghorui
All India Institute of Medical Sciences - Patna

Corresponding Author:[email protected]

Author Profile
Pratap Patra
All India Institute of Medical Sciences - Patna
Author Profile

Abstract

Although under-reported, hemolytic anemia is common with dapsone therapy. However, it is prudent to screen underlying G6PD deficiency to prevent potentially life-threatening episode of intravascular hemolysis in leprosy.
10 Jan 2022Submitted to Clinical Case Reports
21 Jan 2022Submission Checks Completed
21 Jan 2022Assigned to Editor
26 Jan 2022Reviewer(s) Assigned
15 Feb 2022Review(s) Completed, Editorial Evaluation Pending
15 Feb 2022Editorial Decision: Revise Minor
09 Mar 20221st Revision Received
10 Mar 2022Submission Checks Completed
10 Mar 2022Assigned to Editor
10 Mar 2022Review(s) Completed, Editorial Evaluation Pending
20 Mar 2022Editorial Decision: Accept